Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
Clinical Pharmacology and Therapeutics|May 24, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 updateS A Scott, K Sangkuhl, C M Stein, et al.
The American Journal of Cardiology|January 1, 1989
Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study)H L Greene, D W Richardson, A H Barker, et al.
Clinical Pharmacology and Therapeutics|September 25, 2009
Genetic influences on the pharmacokinetics of orally and intravenously administered digoxin as exhibited by monozygotic twinsA L Birkenfeld, J Jordan, U Hofmann, et al.
Clinical Pharmacology and Therapeutics|May 27, 2011
Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levelsN P Tatonetti, J C Denny, S N Murphy, et al.
The Pharmacogenomics Journal|April 4, 2007
Variability in human hepatic MRP4 expression: influence of cholestasis and genotypeU Gradhand, T Lang, E Schaeffeler, et al.
Clinical Pharmacology and Therapeutics|July 15, 2016
A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on MetforminS Goswami, S W Yee, F Xu, et al.
The New England Journal of Medicine|February 21, 2009
Estimation of the warfarin dose with clinical and pharmacogenetic data, T E Klein, R B Altman, et al.
The Pharmacogenomics Journal|August 12, 2015
Attitudes of clinicians following large-scale pharmacogenomics implementationJ F Peterson, J R Field, Y Shi, et al.
Annales D'Endocrinologie|March 16, 2020
Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytesJ E Salem, T Yang, J J Moslehi, et al.
Circulation|February 2, 1999
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and IIS G Priori, J Barhanin, R N Hauer, et al.
Pageof 25